CLU and cancer: Verteporfin inhibits the clusterin gene expression in those GC stem cells and suppresses its viability and growth in vivo, indicating that clusterin-targeted therapy and verteporfin therapy may be useful in repressing cancer growth by HSP90 function regulation [144].